Studies on Relation Between Calcification of Tissues and Biosynthesis of a 59 kDa Sialoprotein from Rat Mandible, Using a Monoclinal Antibody.

使用单斜抗体研究组织钙化与大鼠下颌骨 59 kDa 唾液酸蛋白生物合成之间的关系。

基本信息

  • 批准号:
    01480435
  • 负责人:
  • 金额:
    $ 4.1万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1989
  • 资助国家:
    日本
  • 起止时间:
    1989 至 1990
  • 项目状态:
    已结题

项目摘要

A monoclonal antibody was raised against a mineralized tissue-specific sialoprotein containing no phosphorus using partially purified non-collagenous bone matrix proteins from rats as antigen. Then the sialoprotein was purified by high performance liquid chromatography from rat mandibulae using the monoclinal antibody as a marker. The sialoprotein (59kDa bone sialoprotein ; 59kDa-BSP) with a molecular weight of 59,000 containging 1.4% sialic acid but no detectable phosphorus. Immunochemical studies with the antibody showed that the protein was specific to mineralized tissues such as bone and dentin, and present in osteoblasts, osteocytes and bone matrix. No other soft tissues, such as the cartilage, liver, kidney and periosteum, were stained. However, Western blot analysis showed that plasma contained immunoreactive 59kDa-BSP. The quantitative amino acid composition of 59kDa-BSP resembled that of human alpha_2-HS glycoprotein (A2HSG). Amino acid sequence analyses of the amino-terminal region and four peptide fragments of 59kDa-BSP revealed that about 50% of the amino acids were homologous with those of human A2HSG. We next examined biosynthesis of 59kDa-BSP. When newborn rat calvaria were incubated with radioactive leucine, immunoreactive-59kDa-BSP was detected in their conditioned medium by fluorography. The conditioned medium of primary cultures of osteoblast-rich cells and abult rat hepatocytes also contained radioactive material immunoprecipitated with anti-59kDa-BSP. These results indicate that both hepatocytes and osteoblasts synthesize 59kDa-BSP. Several characteristics, including the amino acid sequence, suggest that 59kDa-BSP may be the rat counterpart of human A2HSG. However, rat 59kDa-BSP is a single peptide, whereas human A2HSG is known to be a heterodimer which is synthesized by the liver, transported in the blood stream and incorporated into calcified tissues.
用部分纯化的大鼠非胶原性骨基质蛋白作为抗原,制备了一种抗矿化组织特异性唾液酸蛋白的单克隆抗体。以单克隆抗体为标记,采用高效液相色谱法从大鼠下颌骨中纯化唾液酸蛋白。唾液蛋白(59 kDa骨唾液蛋白; 59 kDa-BSP),分子量为59,000,含1.4%唾液酸,但未检测到磷。用该抗体进行的免疫化学研究表明,该蛋白对矿化组织如骨和牙本质具有特异性,并存在于成骨细胞、骨细胞和骨基质中。其他软组织如软骨、肝、肾和骨膜均未被染色。Western blot分析显示血浆中含有59 kDa-BSP。59 kDa-BSP的氨基酸组成与人α_2-HS糖蛋白(A2 HSG)相似。氨基酸序列分析表明,59 kDa-BSP与人A2 HSG的氨基酸同源性约为50%。我们接下来研究了59 kDa-BSP的生物合成。新生大鼠颅骨与放射性亮氨酸孵育后,荧光显色法检测到条件培养液中有免疫反应性~ 59 kDa-BSP。富含成骨细胞的原代培养物和成年大鼠肝细胞的条件培养基也含有用抗59 kDa-BSP免疫沉淀的放射性物质。这些结果表明,肝细胞和成骨细胞都合成59 kDa-BSP。包括氨基酸序列在内的几个特征表明,59 kDa-BSP可能是人A2 HSG的大鼠对应物。然而,大鼠59 kDa-BSP是单一肽,而已知人A2 HSG是异源二聚体,其由肝脏合成,在血流中转运并掺入钙化组织中。

项目成果

期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tomokazu Ohnishi, Osamu Nakamura, Naokatu Arakaki, and Yasushi Daikuhara.: "Purification and characterization of rat mandible-derived sialoprotein. (in Japanese)" Seikaq. 61. 875-875, (1989)
Tomokazu Ohnishi、Osamu Nakamura、Naokatu Arakaki 和 Yasushi Daikuhara.:“大鼠下颌衍生唾液酸蛋白的纯化和表征。(日语)”Seikaq。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tomokazu Ohnishi, Naokatu Arakaki, Shuichi Hirono and Yasushi Daikuhara: "Synthesis of rat 59 kDa bone sialoprotein, probably the rat counterpart of human alpha_2-HS glycoprotein, by both hepatocytes and osteoblasts." Journal of Biological Chemistry. (199
Tomokazu Ohnishi、Naokatu Arakaki、Shuichi Hirono 和 Yasushi Daikuhara:“肝细胞和成骨细胞合成大鼠 59 kDa 骨唾液蛋白,可能是人类 alpha_2-HS 糖蛋白的大鼠对应物。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
大西 智和: "ラット骨由来シアロタンパク質の産生細胞" 歯科基礎医学会雑誌. 32(補). 133-133 (1990)
Tomokazu Onishi:“大鼠骨源性唾液酸蛋白产生细胞”日本基础牙科医学会杂志 32(增刊)133-133(1990)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tomokazu OHNISHI: "Purification,characterization and studies on tissue distribution of a 59 kDa bone sialic acid containing protein(59kDa-BSP)from rat mandible using a monoclonal antibody." Calcified Tissue International. (1990)
Tomokazu OHNISHI:“使用单克隆抗体对大鼠下颌骨中含有 59 kDa 骨唾液酸的蛋白 (59kDa-BSP) 进行纯化、表征和组织分布研究。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ohnishi, Tomokazu: "Synthesis of rat 59 kDa bone sialoprotein, probably the rat conterpart of human alpha_2ーHS glycoprotein, by both hepatocytes and osteoblasts." Journal of Biological Chemistry.
Ohnishi, Tomokazu:“肝细胞和成骨细胞合成大鼠 59 kDa 骨唾液酸蛋白,可能是人类 alpha_2ーHS 糖蛋白的大鼠对应物。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAIKUHARA Yasushi其他文献

DAIKUHARA Yasushi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAIKUHARA Yasushi', 18)}}的其他基金

A basic research for use of hepatocyte growth factor (HGF) for diagnosis and treatment of periodontal disease.
利用肝细胞生长因子(HGF)诊断和治疗牙周病的基础研究。
  • 批准号:
    12357011
  • 财政年份:
    2000
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Effect of hepatocyte growth factor/scatter factor on the development and metabolism of bone tissue : relation of regulation on fetuin gene expression.
肝细胞生长因子/分散因子对骨组织发育和代谢的影响:胎球蛋白基因表达调控的关系。
  • 批准号:
    10470391
  • 财政年份:
    1998
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
A new diagnostic method for periodontal diseases by determining hepatocyte growth factor in gingival cervical fluid with a high sensitive ELISA.
高灵敏ELISA检测牙龈宫颈液中肝细胞生长因子的牙周病诊断新方法。
  • 批准号:
    08557100
  • 财政年份:
    1996
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Physiological roles of rat fetuin on bone metabolism
大鼠胎球蛋白对骨代谢的生理作用
  • 批准号:
    08457492
  • 财政年份:
    1996
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Difference in physiological roles of phosphorylated and non-phosphorylated rat fetuin.
磷酸化和非磷酸化大鼠胎球蛋白生理作用的差异。
  • 批准号:
    06454524
  • 财政年份:
    1994
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似国自然基金

分泌性蛋白Zinc-a2-glycoprotein在遗传性扩张型心肌病发生发展中的作用与机制研究
  • 批准号:
    82070391
  • 批准年份:
    2020
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
P-glycoprotein与Rack1和Src相互作用并促进耐药乳腺癌细胞侵袭转移的分子机制研究
  • 批准号:
    81472474
  • 批准年份:
    2014
  • 资助金额:
    85.0 万元
  • 项目类别:
    面上项目

相似海外基金

新奇皮膚バリア因子としてのHistidine-rich glycoprotein機能評価
富含组氨酸糖蛋白作为新型皮肤屏障因子的功能评价
  • 批准号:
    24K18020
  • 财政年份:
    2024
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
リンパ脈管筋腫症病態におけるhistidine-rich glycoproteinの役割解明に関する研究
富含组氨酸糖蛋白在淋巴管平滑肌瘤病病理中作用的研究
  • 批准号:
    24K11332
  • 财政年份:
    2024
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
GLYCOprotein N-glycosylation from non-life to eukaryotes: a Doctoral Network to expand the knowledge on a ubiquitous posttranslational modification
从非生命到真核生物的糖蛋白 N-糖基化:扩展普遍存在的翻译后修饰知识的博士网络
  • 批准号:
    EP/Y032527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Research Grant
Probing functional HIV-1 envelope glycoprotein conformations with novel potent CD4-mimetic compounds
用新型有效的 CD4 模拟化合物探测功能性 HIV-1 包膜糖蛋白构象
  • 批准号:
    10762703
  • 财政年份:
    2023
  • 资助金额:
    $ 4.1万
  • 项目类别:
Combining Molecular Simulations and Biophysical Methods to Characterize Conformational Dynamics of the HIV-1 Envelope Glycoprotein
结合分子模拟和生物物理方法来表征 HIV-1 包膜糖蛋白的构象动力学
  • 批准号:
    10749273
  • 财政年份:
    2023
  • 资助金额:
    $ 4.1万
  • 项目类别:
Clinical impact of Leucine-Rich alpha-2 Glycoprotein in patients with esophageal cancer
富含亮氨酸的 α-2 糖蛋白对食管癌患者的临床影响
  • 批准号:
    23K15487
  • 财政年份:
    2023
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Inhibition or evasion of P-glycoprotein-mediated drug transport
抑制或逃避 P-糖蛋白介导的药物转运
  • 批准号:
    10568723
  • 财政年份:
    2023
  • 资助金额:
    $ 4.1万
  • 项目类别:
Targeting glycoprotein (G) domain-III for pan-lyssavirus nanobody therapeutics
靶向糖蛋白 (G) 结构域 III 用于泛狂犬病病毒纳米抗体治疗
  • 批准号:
    10667756
  • 财政年份:
    2023
  • 资助金额:
    $ 4.1万
  • 项目类别:
Research Initiation Award: Analysis of Glycoprotein Composition and Function of PGE2 EP Receptors in Mammary-derived Cells
研究启动奖:乳腺细胞中 PGE2 EP 受体的糖蛋白组成和功能分析
  • 批准号:
    2300448
  • 财政年份:
    2023
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Standard Grant
Collaborative Research: Cell-free glycoprotein synthesis technology for point-of-care vaccine biomanufacturing
合作研究:用于即时疫苗生物制造的无细胞糖蛋白合成技术
  • 批准号:
    2341123
  • 财政年份:
    2023
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了